ACXP Stock ACXP is expected to report earnings to rise+35% to -24 cents per share on May 15

A.I.dvisor
at Tickeron.com
05/14/24
Loading...
ACXP - Acurx Pharmaceuticals
Acurx Pharmaceuticals Earnings Graph
Q1'24
Est.
$-0.24
Q4'23
Missed
by $0.12
Q3'23
Beat
by $0.03
Q2'23
Missed
by $0.05
Q1'23
Beat
by $0.02
The last earnings report on December 31 showed earnings per share of -37 cents, missing the estimate of -25 cents. P/B Ratio (0.571) is normal, around the industry mean (10.529). P/E Ratio (0.000) is within average values for comparable stocks, (161.363). ACXP's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.435). Dividend Yield (0.000) settles around the average of (0.066) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (258.151). With 11.70K shares outstanding, the current market capitalization sits at 32.12M.
View a ticker or compare two or three
ACXPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
259 Liberty Avenue
Phone
+1 917 533-1469
Employees
4
Web
https://www.acurxpharma.com